可溶性血红蛋白清除受体CD163（sCD163）可预测社区获得性肺炎的死亡率。 - Suppr | 超能文献

相似文献

1

Soluble hemoglobin scavenger receptor CD163 (sCD163) predicts mortality of community-acquired pneumonia.可溶性血红蛋白清除受体CD163（sCD163）可预测社区获得性肺炎的死亡率。

J Infect. 2016 Oct;73(4):375-7. doi: 10.1016/j.jinf.2016.07.004. Epub 2016 Jul 12.

2

Soluble Scavenger Receptor CD163 Is Associated with Severe Acute Kidney Injury in Patients with Hantaan Virus Infection.可溶性清道夫受体CD163与汉坦病毒感染患者的严重急性肾损伤相关。

Viral Immunol. 2015 May;28(4):241-6. doi: 10.1089/vim.2014.0112. Epub 2015 Mar 19.

3

Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.可溶性巨噬细胞来源的 CD163：一种具有可分离触珠蛋白-血红蛋白结合的均一胞外结构域蛋白。

Immunobiology. 2010 May;215(5):406-12. doi: 10.1016/j.imbio.2009.05.003. Epub 2009 Jul 5.

4

Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability.糖尿病患者及Hp 2-2基因型个体中血红蛋白清除受体的下调：对斑块内出血反应及斑块易损性的影响。

Circ Res. 2007 Jul 6;101(1):106-10. doi: 10.1161/CIRCRESAHA.107.149435. Epub 2007 May 24.

5

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.单核细胞/巨噬细胞衍生的可溶性CD163：多发性骨髓瘤中的一种新型生物标志物。

Eur J Haematol. 2014 Jul;93(1):41-7. doi: 10.1111/ejh.12296. Epub 2014 Mar 20.

6

Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.可溶性CD163评估早期类风湿关节炎中的巨噬细胞活性：与疾病活动的关联以及对合成和生物DMARDs的不同反应模式

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):498-502. Epub 2015 May 11.

7

Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.血浆可溶性 CD163 水平可独立预测 HIV-1 感染个体的全因死亡率。

J Infect Dis. 2016 Oct 15;214(8):1198-204. doi: 10.1093/infdis/jiw263. Epub 2016 Jun 28.

8

Scavenger receptor CD163 and its biological functions.清道夫受体CD163及其生物学功能。

Acta Medica (Hradec Kralove). 2009;52(2):57-61.

9

The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis.单核细胞谱系特异性可溶性CD163是冠状动脉粥样硬化的血浆标志物。

Atherosclerosis. 2006 Feb;184(2):342-7. doi: 10.1016/j.atherosclerosis.2005.05.004. Epub 2005 Jun 23.

10

Soluble CD163.可溶性 CD163.

Scand J Clin Lab Invest. 2012 Feb;72(1):1-13. doi: 10.3109/00365513.2011.626868. Epub 2011 Nov 7.

引用本文的文献

1

Pathogenic characteristics of pulmonary infection in hospitalized patients with chronic heart failure and diagnostic value of sTREM-1, sCD163, and sTWEAK.慢性心力衰竭住院患者肺部感染的致病特征及可溶性髓系细胞触发受体-1、可溶性CD163和可溶性肿瘤坏死因子样弱凋亡诱导因子的诊断价值

Pak J Med Sci. 2022 Mar-Apr;38(3Part-I):536-541. doi: 10.12669/pjms.38.3.4758.

2

Systemic corticosteroid therapy augments release of sCD163 by peripheral blood monocytes of asthmatic patients.全身皮质类固醇疗法可增强哮喘患者外周血单核细胞释放可溶性CD163。

Postepy Dermatol Alergol. 2020 Feb;37(1):61-65. doi: 10.5114/ada.2020.93384. Epub 2020 Mar 9.

3